FDA approves Novavax's Covid-19 vaccine
Digest more
Nearly 4,500 cases were pulled from shelves in 23 states after it was found that the affected cans had been mislabeled.
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.
By Stephanie Brown HealthDay ReporterMONDAY, May 19, 2025 (HealthDay News) -- Last week, the U.S. Food and Drug Administration announced a move to improve transparency and strengthen the safety of chemicals used in the nation's food supply.
The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s disease. Fujirebio’s Lumipulse G pTau217/ -Amyloid 1-42 Plasma Ratio was developed for the early detection of amyloid plaques associated with AD in adults aged 55 years and older who show signs of the condition,
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the disease in the United States.
Explore more
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of cognitive decline.
The US Food and Drug Administration has cleared the first-ever blood test for diagnosing Alzheimer's disease, offering a less invasive and simpler alternative for the millions of seniors facing cognitive decline.
1h
ValleyCentral.com on MSNFDA approves first-ever Alzheimer’s blood testA few days ago, the U.S. Food and Drug Administration (FDA) cleared the first blood test to help detect early stages of Alzheimer’s Disease. The blood test
US Food and Drug Administration Commissioner Marty Makary named agency veterans to lead tobacco regulation and inspections, two high-profile areas, according to documents seen by Bloomberg.